Company Name	Date	Time	Location	Session Title
Ultragenyx Pharmaceutical	27 – May	13:30-14:45	Marie Curie Hall Forum 1	Update on the Management of Patients with Homozygous Familial Hypercholesterolaemia (HoFH) More details
New Amsterdam Pharma / Menarini	27 – May	13:30-14:45	Claude Bernard Hall Forum 3	Role of CETP inhibitors in cardiovascular risk reduction: Lessons from the past and the road to the future More details
Novartis / Medscape	27 – May	13:30-14:15	René Leriche Hall Forum 2	Lp(a): The Hidden Heartbreaker Redefining Cardiovascular Health More details
MSD	28 – May	7:30-8:15	Marie Curie Hall Forum 1	Are patients a getting to their lipid goals? More details
Novo Nordisk	28 – May	13:45-14:30	Marie Curie Hall Forum 1	Inflammation: The next frontier in ASCVD care More details
Daiichi Sankyo	28 – May	13:45-14:30	René Leriche Hall Forum 2	HerHeart Symposium: Navigating LDL-C Management for Optimal Cardiovascular Health in Women More details
Novartis	28 – May	14:30-15:30	Claude Bernard Hall Forum 3	Stay committed to your goal: Sustained LDL-C reduction in the long-term  and real-world More details
Amarin	28 – May	14:45-15:30	Marie Curie Hall Forum 1	Beyond LDL-c : Residual risk and Elevated triglycerides More details